Literature DB >> 19329427

Domain interplay mediated by an essential disulfide linkage is critical for the activity and secretion of the metastasis-promoting enzyme autotaxin.

Silvia Jansen1, Maria Andries, Rita Derua, Etienne Waelkens, Mathieu Bollen.   

Abstract

Autotaxin or NPP2 (nucleotide pyrophosphatase/phosphodiesterase 2) is a secreted lysophospholipase-D that promotes metastasis and tumor growth by its ability to generate lysophosphatidic acid. Considerable evidence suggests that inhibitors of NPP2 can be used as a novel therapy for the treatment of cancer. Although most attention is currently directed toward the development of inhibitors of the catalytic site, we have explored whether NPP2 can also be targeted through its non-catalytic nuclease-like domain. We demonstrate here that the catalytic and nuclease-like domains are covalently linked by an essential disulfide bridge between Cys(413) and Cys(805). Within the nuclease-like domain, residues 829-850 are involved in the secretion of NPP2, and Lys(852) is required for the expression of catalytic activity. These data show that the nuclease-like domain is crucial for catalysis by NPP2 and is a possible target to generate inhibitors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19329427      PMCID: PMC2682878          DOI: 10.1074/jbc.M900790200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Structural and catalytic similarities between nucleotide pyrophosphatases/phosphodiesterases and alkaline phosphatases.

Authors:  R Gijsbers; H Ceulemans; W Stalmans; M Bollen
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

2.  Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency.

Authors:  R B Kapust; J Tözsér; J D Fox; D E Anderson; S Cherry; T D Copeland; D S Waugh
Journal:  Protein Eng       Date:  2001-12

3.  Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid.

Authors:  Masayuki Tanaka; Shinichi Okudaira; Yasuhiro Kishi; Ryunosuke Ohkawa; Sachiko Iseki; Masato Ota; Sumihare Noji; Yutaka Yatomi; Junken Aoki; Hiroyuki Arai
Journal:  J Biol Chem       Date:  2006-07-06       Impact factor: 5.157

4.  Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions.

Authors:  Tae Nakasaki; Toshiyuki Tanaka; Shinichi Okudaira; Michi Hirosawa; Eiji Umemoto; Kazuhiro Otani; Soojung Jin; Zhongbin Bai; Haruko Hayasaka; Yoshinori Fukui; Katsuyuki Aozasa; Naoya Fujita; Takashi Tsuruo; Keiichi Ozono; Junken Aoki; Masayuki Miyasaka
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

Review 5.  Therapeutic potential of autotaxin/lysophospholipase d inhibitors.

Authors:  Lorenzo Federico; Zehra Pamuklar; Susan S Smyth; Andrew J Morris
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

6.  Autotaxin: a secreted autocrine/paracrine factor that promotes glioma invasion.

Authors:  Dominique B Hoelzinger; Mitsutoshi Nakada; Tim Demuth; Tyler Rosensteel; Linsey B Reavie; Michael E Berens
Journal:  J Neurooncol       Date:  2007-10-11       Impact factor: 4.130

7.  Virtual screening approaches for the identification of non-lipid autotaxin inhibitors.

Authors:  Abby L Parrill; Uniqua Echols; Tran Nguyen; Truc-Chi T Pham; Adrienne Hoeglund; Daniel L Baker
Journal:  Bioorg Med Chem       Date:  2007-11-12       Impact factor: 3.641

8.  Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells.

Authors:  So Young Yang; Jangsoon Lee; Chang Gyo Park; Seonghwan Kim; Sungyoul Hong; Hyun Cheol Chung; Seong Ki Min; Jeung Whan Han; Hyang Woo Lee; Hoi Young Lee
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

9.  Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D.

Authors:  Laurens A van Meeteren; Volker Brinkmann; Jean Sébastien Saulnier-Blache; Kevin R Lynch; Wouter H Moolenaar
Journal:  Cancer Lett       Date:  2008-04-18       Impact factor: 8.679

10.  Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs.

Authors:  Hidenobu Kanda; Rebecca Newton; Russell Klein; Yuka Morita; Michael D Gunn; Steven D Rosen
Journal:  Nat Immunol       Date:  2008-03-09       Impact factor: 25.606

View more
  10 in total

1.  Location, location, location: a crystal-clear view of autotaxin saturating LPA receptors.

Authors:  Adel Tabchy; Gabor Tigyi; Gordon B Mills
Journal:  Nat Struct Mol Biol       Date:  2011-02       Impact factor: 15.369

Review 2.  Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression.

Authors:  Lorenzo Federico; Kang Jin Jeong; Christopher P Vellano; Gordon B Mills
Journal:  J Lipid Res       Date:  2015-05-14       Impact factor: 5.922

3.  Selective export of autotaxin from the endoplasmic reticulum.

Authors:  Lin Lyu; Baolu Wang; Chaoyang Xiong; Xiaotian Zhang; Xiaoyan Zhang; Junjie Zhang
Journal:  J Biol Chem       Date:  2017-03-15       Impact factor: 5.157

Review 4.  Cellular function and molecular structure of ecto-nucleotidases.

Authors:  Herbert Zimmermann; Matthias Zebisch; Norbert Sträter
Journal:  Purinergic Signal       Date:  2012-05-04       Impact factor: 3.765

5.  Crystal structure of autotaxin and insight into GPCR activation by lipid mediators.

Authors:  Hiroshi Nishimasu; Shinichi Okudaira; Kotaro Hama; Emiko Mihara; Naoshi Dohmae; Asuka Inoue; Ryuichiro Ishitani; Junichi Takagi; Junken Aoki; Osamu Nureki
Journal:  Nat Struct Mol Biol       Date:  2011-01-16       Impact factor: 15.369

Review 6.  Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy.

Authors:  David N Brindley; Fang-Tsyr Lin; Gabor J Tigyi
Journal:  Biochim Biophys Acta       Date:  2012-08-29

Review 7.  Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors.

Authors:  Sang-Yong Lee; Christa E Müller
Journal:  Medchemcomm       Date:  2017-02-09       Impact factor: 3.597

8.  Autotaxin: its role in biology of melanoma cells and as a pharmacological target.

Authors:  Maciej Jankowski
Journal:  Enzyme Res       Date:  2011-03-08

9.  Structural basis of substrate discrimination and integrin binding by autotaxin.

Authors:  Jens Hausmann; Satwik Kamtekar; Evangelos Christodoulou; Jacqueline E Day; Tao Wu; Zachary Fulkerson; Harald M H G Albers; Laurens A van Meeteren; Anna J S Houben; Leonie van Zeijl; Silvia Jansen; Maria Andries; Troii Hall; Lyle E Pegg; Timothy E Benson; Mobien Kasiem; Karl Harlos; Craig W Vander Kooi; Susan S Smyth; Huib Ovaa; Mathieu Bollen; Andrew J Morris; Wouter H Moolenaar; Anastassis Perrakis
Journal:  Nat Struct Mol Biol       Date:  2011-01-16       Impact factor: 15.369

Review 10.  The Expression Regulation and Biological Function of Autotaxin.

Authors:  Xiaotian Zhang; Mengmiao Li; Nan Yin; Junjie Zhang
Journal:  Cells       Date:  2021-04-19       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.